The DNA packaging systems market is growing quickly, with forecasts showing it will add hundreds of millions in revenue between 2025 and 2034, driving sustainable infrastructure worldwide.
Leading Companies in the DNA Packaging Systems Market
In April 2025, Zymo Research Corp disclosed the launch of its updated technology: The Green DNA/RNA Dry Transport System. This latest machine has established the standard for cost-effective, eco-conscious, and room-temperature transportation of DNA and RNA samples, which are perfect for creating libraries for the purpose of a commercial sequencing platform.
In June 2024, Asahi Kasei group and the Bionova Scientific company, a complete service biologics CDMO, have revealed plans to invest USD100 Million to expand into plasmid DNA (pDNA) manufacturing. The centrepiece of the project is the latest 100,000 sq ft. growth and production availability in The Woodlands, Texas ( near Houston).
In January 2025, the Truveta partnership will expand the Regeneron Genetics Centre’s globally top DNA Sequence-connected healthcare database (now counting almost three million de-identified patient volunteers) with the help of a genetic series of up to ten million further patient volunteers, having linked electronic health records, which makes the Truveta Genome Project.
Recent Development
In October 2024, the latest MiSeq i100 range instruments included the XLEAP-SBS chemistry, primarily as it entered two years ago with the launch of Illumina’s NovaSeqX instrument. Furthermore, the latest MiSeq i100 series has DRAGEN Mixed on-board.
In September 2025, Happy Head, an organization that is an expert in hair protection and restoration, revealed the STrandIQ system, which is a DNA-dependent strategy for promoting hair growth. This StrandIQ system includes a DNA Starter Kit, an at-home cheek swab that is implemented to decode how people’s different biology may encourage hair and scalp health.
In August 2025, Klotho Neurosciences, Inc. disclosed that it had officially signed a binding collaboration to start production and growth of its KLTO-202 Gene therapy candidate, utilising the AAVnerGene Inc.
Keypoints
Company Overview
Locations Subsidiaries/Geographic reach
Key Executives
Company Financials
Patents registered
SWOT Analysis
Applications Catered
Strategic collaborations
Recent Developments
Competitive Benchmarking
Proceed To Buy
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.